HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitorsDorte Nielsen, Claus Kamby, Michael Andersson|Cancer Treatment Reviews|2008Cited by 134
Vaccination with p53-peptide?pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I studyInge Marie Svane, Mogens H. Claësson, Anders Elm Pedersen et al.|Cancer Immunology Immunotherapy|2004Cited by 112